Voloridge Investment Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-56,874
Closed -$1.64M 1348
2025
Q2
$1.64M Sell
56,874
-50,731
-47% -$1.5M 0.01% 978
2025
Q1
$3.76M Sell
107,605
-147,159
-58% -$6M 0.01% 851
2024
Q4
$11.3M Sell
254,764
-231,238
-48% -$9.46M 0.04% 534
2024
Q3
$22.2M Sell
486,002
-51,201
-10% -$2.07M 0.08% 345
2024
Q2
$17.8M Sell
537,203
-20,089
-4% -$822K 0.07% 405
2024
Q1
$26.7M Buy
+557,292
New +$32.5M 0.1% 261
2022
Q3
Sell
-24,729
Closed -$2.4M 1586
2022
Q2
$2.4M Buy
24,729
+17,604
+247% +$1.79M 0.01% 954
2022
Q1
$801K Buy
+7,125
New +$759K ﹤0.01% 1176
2021
Q4
Sell
-140,705
Closed -$19.9M 1796
2021
Q3
$19.9M Sell
140,705
-116,639
-45% -$15.7M 0.13% 209
2021
Q2
$33M Sell
257,344
-15,670
-6% -$1.84M 0.23% 99
2021
Q1
$34.9M Buy
273,014
+157,813
+137% +$29.1M 0.26% 92
2020
Q4
$20.7M Buy
115,201
+74,563
+183% +$16.6M 0.17% 136
2020
Q3
$8.91M Buy
+40,638
New +$9.07M 0.07% 286
2019
Q2
Sell
-9,031
Closed -$591K 1010
2019
Q1
$591K Buy
+9,031
New +$546K 0.02% 622

Other funds holding QDEL

Voloridge Investment Management's QDEL Position: Q3 2025 in Review

Voloridge Investment Management sold out of QuidelOrtho (QDEL) in Q3 2025, closing a stake of 56,874 shares — an estimated $1.64M sold.

Voloridge Investment Management first reported a position in QDEL in Q1 2019 and held it in 14 quarters. The position peaked at $34.9M in Q1 2021. 255 funds tracked by Wall St. Rank hold QDEL as of Q3 2025.

  • Voloridge Investment Management reported no remaining QuidelOrtho position as of Q3 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 56,874 QuidelOrtho shares in Q3 2025, an estimated $1.64M.
  • Voloridge Investment Management first reported a position in QuidelOrtho in Q1 2019 and held it in 14 quarters.
  • Voloridge Investment Management's QuidelOrtho position peaked at $34.9M in Q1 2021.
  • 255 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2025.

Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.